Objective: This randomised, multicentre, direct open comparative trial evaluated the efficacy,
treatment convenience, tolerability and safety aspects of transdermal therapeutic system …

There is emerging data supporting the use of TTS‐F (transdermal therapeutic system‐
fentanyl) in opioid naive patients. Our study examines the safety and efficacy of TTS‐F in the …

Purpose: To evaluate effectiveness and safety information of transdermal fentanyl
(TDF)(Duragesic/Durogesic*) and sustained-release oral morphine (SRM) in cancer pain …

Objective: The safety of transdermal fentanyl (TF) in comparison with slow-release oral
morphine (SROM) in moderate-severe pain was assessed. Design: A systematic review of …

Goals of the work: This open compassionate-use prospective registration study evaluated
the tolerability, ease of use and applied doses of transdermal (TTS) fentanyl in adult patients …

Background: Up to now, a transdermal therapeutic system (TTS) of fentanyl has been
applied to cancer patients on opioid analgesics previously treated with mild opioids or …

Cancer patients requiring strong opioid analgesia (n= 202; mean age, 61.5 years; range, 18–
89 years; 55% men) were recruited from 38 United Kingdom palliative care centers into a …

PURPOSE: The aim of this study was to compare the analgesic and adverse effects, doses,
as well as cost of opioid drugs, supportive drug therapy and other analgesic drugs in …

Transdermal therapeutic system-fentanyl (TTS-F) has been extensively studied in cancer
pain management. However, few studies have addressed the long-term management of …

Background: To assess the adverse effects of transdermal opiates treating moderate-severe
cancer pain in comparison with slow release oral morphine. Methods: A systematic review of …